Highly Sensitive Electrochemical Sensor for Anticancer Drug by a Zirconia Nanoparticle-Decorated Reduced Graphene Oxide Nanocomposite

Synergistic integration of ZrO2-enriched reduced graphene oxide-based nanostructures for advanced photodegradation of tetracycline hydrochloride

The escalating demand for the antibiotic drug tetracycline hydrochloride (TCH) contributes to an increased release of its residues into land and water bodies, which poses risks to both aquatic life and human health. Therefore, it is precedence to effectively degrade TCH residues to protect environment from their long-term impacts. In this aspect, the present study entails the synthesis of zirconia (ZrO2) nanostructures and focuses on the enhancement in the catalytic performance of ZrO2 nanostructures by employing reduced graphene oxide (RGO) as a solid support to synthesize ZrO2-enriched RGO-based photocatalysts (ZrO2-RGO) for the degradation of TCH. The study delves into comprehensive spectroscopic and microscopic investigations and their photodegradation assessments. Powder XRD and HR-TEM studies depicted the phase crystallinity and also displayed uniform distribution of ZrO2 nanostructures with spherical morphology within ZrO2-RGO. This corresponds to high surface-to-volume ratios, providing a substantial number of active sites for light absorption and generation of e--h+ pairs. Moreover, the heterojunctions created between RGO and ZrO2 nanostructures promoted the interspecies electron transfer which prolonged the recombination time of e- and h+ than pure ZrO2 nanostructures, accounted for enhanced degradation of TCH using ZrO2-RGO. The photocatalytic activity of as-synthesized materials were examined under visible and UV light irradiation. The degradation efficiency of ~ 73.82% was achieved using ZrO2-RGO-based photocatalyst with rate constant k = 0.007023 min-1 under visible-light illumination. Moreover, under UV-light, the degradation rate was explicated to be k = 0.01017 min-1 with ~ 85.56% degradation of TCH antibiotics within 180 mins. Hence, the synthesized ZrO2-enriched RGO-based photocatalysts represents a promising potential for the effective degradation of pharmaceutical compounds, particularly TCH under visible and UV-light irradiation.

An innovative experimental and mathematical approach in electrochemical sensing for mapping a drug sensor landscape

Our study delves into the examination of an electrochemical sensor through both experimentation and mathematical analysis. The sensor demonstrates the ability to identify a specific antipsychotic medication, namely Chlorpromazine Hydrochloride (CPH), even at incredibly low concentrations, reaching the picomolar level. The identification process relies on the utilization of a Glassy Carbon Electrode (GCE) that has been modified with a ceria-doped zirconia (CeO2/ZrO2) nanocomposite. The nanocomposite was synthesized using the co-precipitation technique and extensively characterized through various analytical methods. It is crucial to detect the presence of CPH as an overdose can result in hyperactivity and severe bipolar disorders among both children and adults. The average size of the nanocomposite was estimated to be 10 nm. The electrode surface area after CeO2/ZrO2 modification of the GCE was found to be 0.059 cm2, which was significantly higher than the electrode surface area of the bare GCE (0.0307 cm2). The limit of detection and limit of quantification for CPH were calculated to be 99.3 pM and 3.010 nM, respectively, with the linear dynamic range of CPH detection found to be between 0.10 and 1.90 μM. The modified sensor electrode was tested on human urine samples with good recoveries and exhibited high selectivity, repeatability, reproducibility, and long-term stability. The experimental voltammograms and the simulated stochastic voltammograms exhibited a fair amount of agreement. Examination of the experimental findings alongside analytical and numerical solutions enables a comprehensive analysis of the factors influencing the outcome of electrochemical measurements. The precise findings can be leveraged for the development of efficient sensing devices for medical diagnostics and environmental monitoring.

Metal-free carbon-based anode for electrochemical degradation of tetracycline and metronidazole in wastewater

Degradation of antibiotics through electrocatalytic oxidation has recently been comprehended as a promising strategy in wastewater treatment. Herein, nitrogen and sulphur doped graphene oxide (N,S-rGO) nanosheets were synthesized and employed as metal-free anodic material for electrochemical degradation of antibiotics, viz. metronidazole (MNZ) and tetracycline (TC). The synthesized anodic material was characterized using various spectral techniques and further the electrochemical behaviour of N,S-rGO was thoroughly examined. Thereafter, the N,S-rGO material was then employed as the anode material towards the electrocatalytic degradation of antibiotics. Parameters such as initial concentration of the antibiotics and current densities were varied and their effect towards the degradation of MNZ and TC were probed. Notably, the N,S-rGO based anode has shown impressive removal efficiency of 99% and 98.5%, after 120 min of reaction time for MNZ and TC, respectively, under optimized conditions. The obtained results including the kinetic parameters, removal efficiency and electrical efficiency ensure that the prepared anodic material has huge prospective towards real-time application for removal of antibiotics from water.

Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers

Breast cancer is categorized as the most widespread cancer type among women globally. On-time diagnosis can decrease the mortality rate by making the right decision in the therapy procedure. These features lead to a reduction in medication time and socioeconomic burden. The current review article provides a comprehensive assessment for breast cancer diagnosis using nanomaterials and related technologies. Growing use of the nano/biotechnology domain in terms of electrochemical nanobiosensor designing was discussed in detail. In this regard, recent advances in nanomaterial applied for amplified biosensing methodologies were assessed for breast cancer diagnosis by focusing on the advantages and disadvantages of these approaches. We also monitored designing methods, advantages, and the necessity of suitable (nano) materials from a statistical standpoint. The main objective of this review is to classify the applicable biosensors based on breast cancer biomarkers. With numerous nano-sized platforms published for breast cancer diagnosis, this review tried to collect the most suitable methodologies for detecting biomarkers and certain breast cancer cell types.

Label-Free Electrochemiluminescence Nano-aptasensor for the Ultrasensitive Detection of ApoA1 in Human Serum

A molybdenum sulfide/zirconium oxide/Nafion (MoS₂/ZrO₂/Naf) based electrochemiluminescence (ECL) aptasensor for the selective and ultrasensitive detection of ApoA1 is proposed, with Ru(bpy)₃ ²⁺ as the luminophore. The chitosan (CS) modification on the nanocomposite layer allowed glutaraldehyde (GLUT) cross-linking, resulting in the immobilization of ApoA1 aptamers. Scanning electron microscopy, tunneling electron microscopy, and energy dispersive X-ray spectroscopy were used to characterize the nanocomposite, while electrochemiluminescence (ECL), cyclic voltammetry, and electrochemical impedance spectroscopy were used to analyze the aptasensor assembly. The nanocomposite was used as an electrode modifier, which increased the intensity of the ECL signal. Due to the anionic environment produced on the sensor surface following the specific interaction of the ApoA1 biomarker with the sensor, more Ru(bpy)₃ ²⁺ were able to be electrostatically attached to the aptamer-ApoA1 complex, resulting in enhanced ECL signal. The ECL aptasensor demonstrated outstanding sensitivity for ApoA1 under optimal experimental conditions, with a detection limit of 53 fg/mL and a wide linear dynamic range of 0.1-1000 pg/mL. The potential practical applicability of this aptasensor was validated by analyzing ApoA1 in human serum samples, with recovery rates of 94-108% (n = 3). The proposed assay was found to be substantially better compared to the commercially available enzyme-linked immunosorbent assay method, as reflected from over 1500 times improvement in the detection limit for ApoA1.

A bibliometric analysis of graphene in acetaminophen detection: Current status, development, and future directions

Acetaminophen is a widely used analgesic throughout the world. Detection of acetaminophen has particular value in pharmacy and clinics. Electrochemical sensors assembled with advanced materials are an effective method for the rapid detection of acetaminophen. Graphene-based carbon nanomaterials have been extensively investigated for potential analytical applications in the last decade. In this article, we selected papers containing both graphene and acetaminophen. Bibliometrics was used to analyze the relationships and trends among these papers. The results show that the topic has grown at a high rate since 2009. Among them, the detection of acetaminophen by an electrochemical sensor based on graphene is the most important direction. Graphene has moved from being a primary sensing material to a substrate for immobilization of other active ingredients. In addition, the degradation of acetaminophen using graphene-modified electrodes is also an important direction. We analyzed the research history and current status of this topic through bibliometrics. Authors, institutions, countries, and key literature were discussed. We also proposed perspectives for this topic.

Green Synthesis of Trimetallic Nanocomposite (Ru/Ag/Pd)-Np and Its In Vitro Antimicrobial and Anticancer Activities

In this study, we used the aqueous extract of garlic tunicate leaf to reduce a mixture of equal amounts of ruthenium chloride, silver nitrate, and palladium acetate for the biosynthesis of ruthenium/silver/palladium trimetallic nanocomposite (Ru/Ag/Pd)-Np. Some physicochemical tools were used for nanocomposite characterization, including Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), thermal gravimetric analysis (TGA), UV-Vis spectroscopy (UV-Vis), scanning electron microscope (SEM), and transmittance electron microscope (TEM). XRD revealed that the crystal size of the nanocomposite is 15.67 nm. The TEM images showed that the particle size ranged 50–90 nm. The antimicrobial efficacy of the nanocomposite was examined against Aspergillus flavus, Aspergillus niger, Candida albicans, Candida glabrata, Escherichia coli, and Bacillus cereus. The results showed a potent antimicrobial activity toward all tested microorganisms. (Ru/Ag/Pd)-Np showed antiproliferative activity against Caco-2, HepG2, and K562 cell lines. The antiproliferative potential of (Ru/Ag/Pd)-Np was significantly improved following UV irradiation.

Electrochemistry as a Powerful Tool for Investigations of Antineoplastic Agents: A Comprehensive Review

Cancer is most frequently treated with antineoplastic agents (ANAs) that are hazardous to patients undergoing chemotherapy and the healthcare workers who handle ANAs in the course of their duties. All aspects related to hazardous oncological drugs illustrate that the monitoring of ANAs is essential to minimize the risks associated with these drugs. Among all analytical techniques used to test ANAs, electrochemistry holds an important position. This review, for the first time, comprehensively describes the progress done in electrochemistry of ANAs by means of a variety of bare or modified (bio)sensors over the last four decades (in the period of 1982-2021). Attention is paid not only to the development of electrochemical sensing protocols of ANAs in various biological, environmental, and pharmaceutical matrices but also to achievements of electrochemical techniques in the examination of the interactions of ANAs with deoxyribonucleic acid (DNA), carcinogenic cells, biomimetic membranes, peptides, and enzymes. Other aspects, including the enantiopurity studies, differentiation between single-stranded and double-stranded DNA without using any label or tag, studies on ANAs degradation, and their pharmacokinetics, by means of electrochemical techniques are also commented. Finally, concluding remarks that underline the existence of a significant niche for the basic electrochemical research that should be filled in the future are presented.

Strategies, advances, and challenges associated with the use of graphene-based nanocomposites for electrochemical biosensors

Graphene is an intriguing two-dimensional honeycomb-like carbon material with a unique basal plane structure, charge carrier mobility, thermal conductivity, wide electrochemical spectrum, and unusual physicochemical properties. Therefore, it has attracted considerable scientific interest in the field of nanoscience and bionanotechnology. The high specific surface area of graphene allows it to support high biomolecule loading for good detection sensitivity. As such, graphene, graphene oxide (GO), and reduced GO are excellent materials for the fabrication of new nanocomposites and electrochemical sensors. Graphene has been widely used as a chemical building block and/or scaffold with various materials to create highly sensitive and selective electrochemical sensing microdevices. Over the past decade, significant advancements have been made by utilizing graphene and graphene-based nanocomposites to design electrochemical sensors with enhanced analytical performance. This review focus on the synthetic strategies, as well as the structure-to-function studies of graphene, electrochemistry, novel multi nanocomposites combining graphene, limit of detection, stability, sensitivity, assay time. Finally, the review describes the challenges, strategies and outlook on the future development of graphene sensors technology that would be usable for the internet of things are also highlighted.

Simultaneous and selective electrochemical sensing of methotrexate and folic acid in biological fluids and pharmaceutical samples using Fe3O4/ppy/Pd nanocomposite modified screen printed graphite electrode

The purpose of this study was to fabricate an electrochemical sensor for the detection of methotrexate and folic acid based on a screen-printed graphite electrode (SPGE) modified with prepared iron oxide (Fe₃O₄)/polypyrrole (ppy)/Palladium (Pd) nanocomposite. Transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FT-IR) techniques were employed to characterize the Fe₃O₄/ppy/Pd nanocomposite. The produced modifier was used to induce a remarkable electrocatalytic impact relative to the oxidation of methotrexate, which caused the potential peak shift to a less positive amount (from 800 mV to about 500 mV) and improved the peak current (from 5.3 μA to about 16 μA). Methotrexate peak current was linearly dependent on its concentration from 0.03100.0 μM and the limit of detection (LOD) was estimated at 7.0 nM. The methotrexate and folic acid were co-detected by the proposed sensor. The experimental results indicated that the oxidation peaks of methotrexate and folic acid were separated about 200 mV in phosphate buffer solution (PBS) at pH 7.0. Fe₃O₄/ppy/Pd/SPGE was successfully able to detect methotrexate and folic acid in pharmaceutical and biological samples with excellent recovery.

Highly sensitive detection of anti-cancer drug based on bimetallic reduced graphene oxide nanocomposite

Herein, we describe a high-performance electrochemical sensor for the detection of regorafenib (REG) using bimetallic Pd-Ru nanoparticles anchored on pomegranate peel extract (PPE) derived reduced graphene oxide (Pd-Ru/rGO). PPE was employed to neutralize the extremely acidic graphene then cast-off along with the metal precursor for the duration of the chemical reduction to accomplish well dispersed Pd-Ru nanoparticles. Bimetallic Pd-Ru/rGO nanocomposites were synthesized using a facile chemical reduction method. Under optimal conditions, based on the differential pulse voltammetric studies it has been confirmed that the fabricated sensors has good electrocatalytic activity toward the detection of REG, spanning over the linear dynamic range of 0.5-300 nM. Moreover, the sensor exhibited a low limit of detection of 1.6 nM and a limit of quantification of 4.8 nM. The electrochemical sensor unveiled admirable selectivity and sensitivity, reproducibility, and repeatability. The fabricated sensor was suitable for real sample analysis (pharmaceutical tablet, human blood plasm, wastewater) with satisfactory recovery. The strategy presented herein can be employed in the development of electrochemical sensors for other target analytes.

Voltammetric detection of sumatriptan in the presence of naproxen using Fe3O4@ZIF-8 nanoparticles modified screen printed graphite electrode

A novel electrochemical sensing platform was designed and prepared for the simultaneous detection of sumatriptan and naproxen by exploiting the prowess of the Fe₃O₄@ZIF-8 nanoparticles (NPs); as-synthesized Fe₃O₄@ZIF-8 NPs were characterized by energy-dispersive X-ray spectroscopy, fourier transform infrared spectroscopy, X-ray diffraction, field emission scanning electron microscopy (FESEM), transmission electron microscopy and thermal gravimetric analysis. The immobilized Fe₃O₄@ZIF-8 NPs on a screen printed graphite electrode (SPGE) was evaluated electrochemically via cyclic voltammetry, linear sweep voltammetry, and differential pulse voltammetry as well as chronoamprometery means; Fe₃O₄@ZIF-8/SPGE exhibited good sensing performance for sumatriptan in a range of 0.035–475.0 µM with detection limit of 0.012 µM. Also, Fe₃O₄@ZIF-8/SPGE exhibited good sensing performance for naproxen in a range of 0.1–700.0 µM with detection limit of 0.03 µM. The modified electrode showed two separate oxidative peaks at 620 mV for sumatriptan and at 830 mV for naproxen with a peak potential separation of 210 mV which was large enough to detect the two drugs simultaneously besides being stable in the long-run with considerable reproducibility. Real sample analyses were carried out to identify the function of fabricated electrode in sensing applications wherein trace amounts of sumatriptan and naproxen could be identified in these samples.

Graphene Biodevices for Early Disease Diagnosis Based on Biomarker Detection

The early diagnosis of diseases plays a vital role in healthcare and the extension of human life. Graphene-based biosensors have boosted the early diagnosis of diseases by detecting and monitoring related biomarkers, providing a better understanding of various physiological and pathological processes. They have generated tremendous interest, made significant advances, and offered promising application prospects. In this paper, we discuss the background of graphene and biosensors, including the properties and functionalization of graphene and biosensors. Second, the significant technologies adopted by biosensors are discussed, such as field-effect transistors and electrochemical and optical methods. Subsequently, we highlight biosensors for detecting various biomarkers, including ions, small molecules, macromolecules, viruses, bacteria, and living human cells. Finally, the opportunities and challenges of graphene-based biosensors and related broad research interests are discussed.

An antifouling impedimetric sensor based on zinc oxide embedded polyvinyl alcohol nanoplatelets for wide range dopamine determination in the presence of high concentration ascorbic acid

Dopamine determination is of great importance for the early diagnosis of neurological diseases. However, dopamine sensors mostly encounter important challenges such as surface fouling and interference of co-existing biochemicals. Here, nanoplatelets of zinc oxide embedded polyvinyl alcohol (NP-ZnO/PVA) were utilized for providing an efficient fouling-free surface for selective dopamine determination in concentrations as high as 3 mM of dopamine in the presence of ascorbic acid interference. The fouling-free properties was provided mainly by pH-inducibility of the NP-ZnO/PVA nanocomposite at the rationally adjusted sensing conditions. ZnO plays a vital role in the electrocatalytic oxidation of dopamine, and PVA provides surface functional groups that minimize the surface interactions with interferences or fouling agents. The NP-ZnO/PVA nanocomposite fabrication process was performed by PVA assisted ZnO electro-synthesis onto the surface of fluorine-doped tin oxide (FTO) conducting glass. The fabricated FTO/NP-ZnO/PVA sensor was characterized utilizing FE-SEM, EDX, XRD, TGA-DTG, BET-BJH and FTIR techniques. Impedimetric determination of dopamine was performed in the wide linear range from 20.0 nM to 3.0 mM with a low detection limit of 5.0 nM. The applicability of FTO/NP-ZnO/PVA for dopamine determination was successfully tested in real samples. The NP-ZnO/PVA provides a great prospective to be an efficacious material for the construction of dopamine electrochemical sensing platforms.

Zirconia Nanoparticles Induce HeLa Cell Death Through Mitochondrial Apoptosis and Autophagy Pathways Mediated by ROS

Zirconia nanoparticles (ZrO₂ NPs) are commonly used in the field of biomedical materials, but their antitumor activity and mechanism is unclear. Herein, we evaluated the anti-tumor activity of ZrO₂ NPs and explored the anti-tumor mechanism. The results of in vitro and in vivo experiments showed that the level of intracellular reactive oxygen species (ROS) in HeLa cells was elevated after ZrO₂ NPs treatment. Transmission electron microscopy (TEM) showed that after treatment with ZrO₂ NPs, the mitochondria of HeLa cells were swollen, accompanied with the induction of autophagic vacuoles. In addition, flow cytometry analysis showed that the apoptotic rate of HeLa cells increased significantly by Annexin staining after treatment with ZrO₂ NPs, and the mitochondrial membrane potential (MMP) was reduced significantly. The proliferation of HeLa cells decreased as indicated by reduced Ki-67 labeling. In contrast, TUNEL-positive cells in tumor tissues increased after treatment with ZrO₂ NPs, which is accompanied by increased expression of mitochondrial apoptotic proteins including Bax, Caspase-3, Caspase-9, and Cytochrome C (Cyt C) and increased expression of autophagy-related proteins including Atg5, Atg12, Beclin-1, and LC3-II. Treating HeLa cells with N-acetyl-L-cysteine (NAC) significantly reduced ROS, rate of apoptosis, MMP, and in vivo anti-tumor activity. In addition, apoptosis- and autophagy-related protein expressions were also suppressed. Based on these observations, we conclude that ZrO₂ NPs induce HeLa cell death through ROS mediated mitochondrial apoptosis and autophagy.

A review on analytical methods with special reference to electroanalytical methods for the determination of some anticancer drugs in pharmaceutical and biological samples

It is widely accepted that cancer, the second leading cause of death, is a morbidity with big impacts on the global health. In the last few years, chemo-therapeutic treatment continually induces alone most lengthy consequents, which is extremely harmful for the physiological and psychological health of the patients. In the present research, we discuss the recent techniques for employed for extraction, and quantitative determination of such compounds in pharmaceutical, and biological specimens. In the frame of this information, this review aims to provide basic principles of chromatography, spectroscopy, and electroanalytical methods for the analysis of anticancer drugs published in the last three years. The review also describes the recent developments regarding enhancing the limit of detection (LOD), the linear dynamic range, and so forth. The results show that the LOD for the chromatographic techniques with the UV detector was obtained equaled over the range 2.0 ng mL^-1-0.2 μg mL^-1, whereas the LOD values for analysis by chromatographic technique with the mass spectrometry (MS) detector was found between 10.0 pg mL^-1-0.002 μg mL^-1. The biological fluids could be directly injected to capillary electrophoresis (CE) in cases where the medicine concentration is at the contents greater than mg L^-1 or g L^-1. Additionally, electrochemical detection of the anticancer drugs has been mainly conducted by the voltammetry techniques with diverse modified electrodes, and lower LODs were estimated between 3.0 ng mL^-1-0.3 μg mL^-1. It is safe to say that the analyses of anticancer drugs can be achieved by employing a plethora of techniques such as electroanalytical, spectroscopy, and chromatography techniques.

A novel MIP-ECL sensor based on RGO-CeO2NP/Ru(bpy)32+-chitosan for ultratrace determination of trimipramine

A novel molecularly imprinted polymer (MIP)-electrochemiluminescence (MIP-ECL) sensor based on CeO2NP-RGO/Ru(bpy)32+-MIP-chitosan was introduced for the ultrasensitive and ultraselective detection of trimipramine (TRI). TRI-MIP was synthesized via the precipitation polymerization process. A nanocomposite of reduced graphene oxide decorated with ceria (CeO2NP-RGO) was synthesized through a facile sonochemical process. CeO2NP-RGO was utilized for modifying the surface of an electrode which consequently led to an excellent electrical conductivity, enhanced electrochemical and ECL characteristics of Ru(bpy)32+. Electrochemical and ECL behaviors of the MIP-ECL sensor were evaluated. Accordingly, the ECL intensity was significantly enhanced via TRI molecule adsorption on the MIP composite film. The prepared MIP-ECL sensor demonstrated high sensitivity and selectivity as well as good reproducibility and stability for TRI determination under the applied optimal conditions. The assays response for TRI concentration was linear in the range of 0.2-100 pM with a 0.995 correlation coefficient. The limit of detection (LOD) was as small as 0.025 pM (S/N = 3). The recoveries between 91-107% for human serum (RSDs < 4.1%) and 94-104.6% for human urine (RSDs < 3.4%) approve that the MIP-ECL sensor can be used for precise detection of TRI in complex biological matrices. Ultimately, this sensor was utilized successfully for the analysis of TRI in human serum and urine samples without any special pretreatment.

Well-Designed Au Nanorod-Doped Cu2O Core-Shell Nanocube-Embedded Reduced Graphene Oxide Composite for Efficient Removal of a Water Pollutant Dye

To ensure environmental safety, the removal of organic pollutants has gained increasing attention globally. We have synthesized uniform Au nanorod (NR)-doped Cu₂O core-shell nanocubes (CSNCs) via a seed-mediated route embedded on the surface of rGO sheets. The Au NRs@Cu₂O/rGO nanocomposite was characterized using various techniques such as transmission electron microscopy (TEM), atomic force microscopy (AFM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and Fourier-transform infrared (FT-IR) and Raman spectroscopies. The scanning TEM-energy-dispersive spectroscopy (STEM-EDS) elemental mapping of the AuNRs@Cu₂O/rGO nanocomposite indicates that the Au NR (40 nm) is fully covered with the Cu₂O particles (∼145 nm) as a shell. N₂ gas sorption analysis shows that the specific surface area of the composite is 205.5 m²/g with a mesoporous character. Moreover, incorporation of Au NRs@Cu₂O CSNCs increases the nanogaps around the nanoparticles and suppresses the stacking/bundling of rGO, which significantly influences the pore size and increase the surface area. A batch adsorption experiment was carried out under various parameters, such as the effect of pH, contact time, temperature, initial dye concentration, and adsorbent dosage, for the removal of methylene blue (MB) in aqueous solution. The high surface area and mesoporosity can cause the adsorption capacity to reach equilibrium within 20 min with a 99.8% removal efficiency. Both kinetic and isotherm data were obtained and fitted very well with the pseudo-second-order kinetic and Langmuir isotherm model. The Langmuir isotherm revealed an excellent dye sorption capacity of 243.9 mg/g at 298 K. Moreover, after five adsorption cycles, the dye removal efficiency decreased from 99 to 86%. This novel route paves a new path for heterogeneous adsorbent synthesis, which is useful for catalysis and electrochemical applications.

Recent Advances in Electrochemical Sensors and Biosensors for Detecting Bisphenol A

In recent years, several studies have focused on environmental pollutants. Bisphenol A (BPA) is one prominent industrial raw material, and its extensive utilization and release into the environment constitute an environmental hazard. BPA is considered as to be an endocrine disruptor which mimics hormones, and has a direct relationship to the development and growth of animal and human reproductive systems. Moreover, intensive exposure to the compound is related to prostate and breast cancer, infertility, obesity, and diabetes. Hence, accurate and reliable determination techniques are crucial for preventing human exposure to BPA. Experts in the field have published general electrochemical procedures for detecting BPA. The present timely review critically evaluates diverse chemically modified electrodes using various substances that have been reported in numerous studies in the recent decade for use in electrochemical sensors and biosensors to detect BPA. Additionally, the essential contributions of these substances for the design of electrochemical sensors are presented. It has been predicted that chemically modified electrode-based sensing systems will be possible options for the monitoring of detrimental pollutants.

Platelet-Membrane-Camouflaged Zirconia Nanoparticles Inhibit the Invasion and Metastasis of Hela Cells

Zirconia nanoparticles (ZrO2 NPs) are widely applied in the field of biomedicine. In this study, we constructed a nanoplatform of ZrO2 NPs coated with a platelet membrane (PLTm), named PLT@ZrO2. PLTm nanovesicles camouflage ZrO2 NPs, prevent nanoparticles from being cleared by macrophage, and target tumor sites. Compared to ZrO2 alone, PLT@ZrO2 is better at inhibiting the invasion and metastasis of Hela cells in vitro and in vivo. In vitro, PLT@ZrO2 inhibited the growth and proliferation of Hela cells. Scratch-wound healing recovery assay demonstrated that PLT@ZrO2 inhibited Hela cells migration. Transwell migration and invasion assays showed that PLT@ZrO2 inhibited Hela cells migration and invasion. In vivo, PLT@ZrO2 inhibited the tumor growth of Xenograft mice and inhibited the lung and liver metastasis of Hela cells. Immunofluorescence and Western blotting results showed that anti-metastasis protein (E-cadherin) was upregulated and pro-metastasis proteins (N-cadherin, Smad4, Vimentin, E-cadherin,β-catenin, Fibronectin, Snail, Slug, MMP2, Smad2) were down-regulated. Our study indicated that PLT@ZrO2 significantly inhibits tumor growth, invasion, and metastasis.

Rapid detection of low concentration CO using Pt-loaded ZnO nanosheets

Unloaded and Pt-loaded ZnO nanosheets with 120-170 nm sizes were successfully synthesized by a facile one-pot hydrothermal route followed by a calcination treatment. The as-synthesized samples were characterized by X-ray diffraction (XRD), field-emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), and X-ray photoelectron spectroscopy (XPS). It can be clearly observed that Pt nanoparticles with the diameter of 3-5 nm were uniformly loaded on the surface of ZnO nanosheets. A contrastive study based on CO gas sensing performance of bare ZnO and Pt/ZnO was carried out. According to the measurement results, the loading of Pt remarkably upgraded the sensing capability toward CO. The 0.50 at.% Pt/ZnO based gas sensor exhibited an obvious response value of 3.57 toward 50 ppm CO and fast response/recovery time (6/19 s). Besides, the detection limit was as low as 0.10 ppm and the optimal operating temperature was decreased from 210 °C to 180 °C. The enhanced CO sensing performance by Pt nanoparticles could be attributed to the combination of chemical sensitization and electronic sensitization. The 0.50 at.% Pt/ZnO is an efficient sensor material for rapidly detecting low-concentration CO.

A label-free electrochemical aptasensor based on 3D porous CS/rGO/GCE for acetamiprid residue detection

A novel label-free electrochemical aptasensor was fabricated based on a three-dimensional porous electrode (3D-CS/rGO/GCE) for the detection of acetamiprid residues. The sensing signal was generated by the DNA itself. The porous electrode was prepared by electrodeposition in situ and characterized by scanning electron microscope (SEM), cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). These results indicated that the porous electrode has a uniform nanoporous structure, high active area, and excellent conductivity, leading to improve the transmission efficiency of current signals. The 3D-CS/rGO/GCE was used to increase a load of acetamiprid aptamer on the electrode. Meanwhile, DNA self-assembly strategy was used to further increase the DNA amounts. Thus the electrochemical current was amplified significantly due to increased phosphate group amounts by the above synergistic effect. The determination of acetamiprid residues using square wave voltammetry (SWV) showed good sensitivity, with the linear range from 0.1 pM to 0.1 μM and the detection limit was 71.2 fM. The label-free electrochemical aptasensor was also used to detect acetamiprid residues in tea samples with satisfactory results.

An ultrasensitive electrochemical anti-lysozyme aptasensor with biorecognition surface based on aptamer/amino-rGO/ionic liquid/amino-mesosilica nanoparticles

In this work, a novel method based on aptamers is proposed for electrochemical measurement of lysozyme. To this end, screen-printed carbon electrode (SPCE) was modified with a nanocomposite made from amino-reduced graphene oxide (Amino-rGO) synthesized from natural graphite powder, an ionic liquid (IL), and amino-mesosilica nanoparticles (Amino-MSNs). The composition of the nanocomposite (Amino-rGO/IL/Amino-MSNs) results in high thermal and chemical stability, conductivity, surface-to-volume ratio, cost efficiency, biocompatibility, and great bioelectrocatalysis characteristics. Presence of numerous amino groups, as well as remaining oxygen defects in rGO, provides a suitable site for immobilization of aptamers. Furthermore, use of this nanocomposite leads to considerable enhancement of the electrochemical signal and improved method sensitivity. Covalent coupling of aptamer's amino groups with that of the nanocomposite using glutaraldehyde (GLA) as a linker helps immobilize amino-linked lysozyme aptamers (Anti-Lys aptamers) on nanocomposite. The modified electrode was characterized using electrochemical methods such as cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS). The immobilized aptamer selectively adsorbs lysozyme (Lys) on the electrode interface, leading to increased Charge Transfer Resistance (R_CT) in EIS and decrease in the DPV peak currents which are used as analytical signals. Two separate calibration curves were drawn using the data acquired from EIS and DPV. The prepared anti-Lys aptasensor has two very low LODs equal to 2.1 and 4.2 fmol L^-1 with wide detection ranges of 10 fmol L^-1 to 200 nmol L^-1, and 20 fmol L^-1 to 50 nmol L^-1 for EIS and DPV calibration curves, respectively. The SPCE/Amino-rGO/IL/Amino-MSNs/APT also showed high reproducibility, specificity, sensitivity, and rapid response to Lys which has various applications in fields of bioengineering and biomedicine.

Graphene Oxide⁻Platinum Nanoparticle Nanocomposites: A Suitable Biocompatible Therapeutic Agent for Prostate Cancer

Metal nanoparticles and the combination of metal nanoparticles with graphene oxide are widely used in environmental, agriculture, textile, and therapeutic applications. The effect of graphene oxide-green platinum nanoparticles (GO-PtNPs) on human prostate cancer cells (LNCaP) is unclear. Therefore, this study aimed to synthesize a nanocomposite of GO-PtNPs and evaluate their effect on prostate cancer cells. Herein, we synthesized GO-PtNPs using vanillin and characterized GO-PtNPs. GO-PtNP cytotoxicity in LNCaP cells was demonstrated by measuring cell viability and proliferation. Both decreased in a dose-dependent manner compared to that by GO or PtNPs alone. GO-PtNP cytotoxicity was confirmed by increased lactate dehydrogenase release and membrane integrity loss. Oxidative stress induced by GO-PtNPs increased malondialdehyde, nitric oxide, and protein carbonyl contents. The effective reactive oxygen species generation impaired the cellular redox balance and eventually impaired mitochondria by decreasing the membrane potential and ATP level. The cytotoxicity to LNCaP cells was correlated with increased expression of proapoptotic genes (p53, p21, Bax, Bak, caspase 9, and caspase 3) and decreased levels of antiapoptotic genes (Bcl2 and Bcl-xl). Activation of the key regulators p53 and p21 inhibited the cyclin-dependent kinases Cdk2 and Cdk4, suggesting that p53 and p21 activation in GO-PtNP-treated cells caused genotoxic stress and apoptosis. The increased expression of genes involved in cell cycle arrest and DNA damage and repair, and increased levels of 8-oxo-deoxyguanosine and 8-oxoguanine suggested that GO-PtNPs potentially induce oxidative damage to DNA. Thus, GO-PtNPs are both cytotoxic and genotoxic. LNCaP cells appear to be more susceptible to GO-PtNPs than to GO or PtNPs. Therefore, GO-PtNPs have potential as an alternate and effective cancer therapeutic agent. Finally, this work shows that the combination of graphene oxide with platinum nanoparticles opens new perspectives in cancer therapy. However further detailed mechanistic studies are required to elucidate the molecular mechanism of GO-PtNPs induced cytotoxicity in prostate cancer.

A review on graphene-based nanocomposites for electrochemical and fluorescent biosensors

Biosensors with high sensitivity, selectivity and a low limit of detection, reaching nano/picomolar concentrations of biomolecules, are important to the medical sciences and healthcare industry for evaluating physiological and metabolic parameters.